# Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR TID and Pelubiprofen SR (as a Pelubiprofen 90 mg) Tablet QD in Healthy Subjects

> **NCT01776697** · PHASE1 · COMPLETED · sponsor: **Daewon Pharmaceutical Co., Ltd.**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** pelubiprofen (30mg) tablet IR
- **DRUG:** pelubiprofen SR (as a pelubiprofen 90 mg) tablet

## Key facts

- **NCT ID:** NCT01776697
- **Lead sponsor:** Daewon Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** — (—)
- **Last updated:** 2013-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01776697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01776697, "Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR TID and Pelubiprofen SR (as a Pelubiprofen 90 mg) Tablet QD in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01776697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*